5
Apollo Ingredients Ltd
INDSOYALTD NSE
Apollo Ingredients Ltd
Commercial ServicesNSE: INDSOYALTD BSE: APOLLOIN Diversified Services
Key Fundamentals
MicrocapDiversified ServicesCommercial ServicesMarket Cap
₹115 Cr
Volatility
High Risk
P/E Ratio
162.9
EBITDA
₹1.10 Cr
Return on Equity
10.14%
Debt to Equity
0
Book Value
₹6.72
EPS
₹0
52W High
₹110.78
52W Low
₹5.43
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Apollo Ingredients Ltd insights
29 extracted metrics + investor summaries across FY15–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
1- Company is almost debt free.
Weaknesses
4- Stock is trading at 16.5 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 13.4% over last 3 years.
- Debtor days have increased from 27.8 to 42.5 days.
Growth Rate
Revenue Growth
61.29% ↗
Net Income Growth
600.00% ↗
Cash Flow Change
175.00% ↗
ROE
32.90% ↗
ROCE
32.40% ↗
EBITDA Margin (Avg.)
386.08% ↗
Quarterly Results
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 1 | 0.5 | 0.8 | 1.09 | 0.69 | 0.56 | 0.57 | 2.77 | 1.01 |
| Expenses | 0.03 | 0.05 | 0.03 | 0.03 | 0.8 | 0.5 | 0.99 | 0.95 | 0.53 | 0.67 | 0.55 | 1.9 | 0.91 |
| Operating Profit | -0.03 | -0.05 | -0.03 | -0.03 | 0.2 | 0 | -0.19 | 0.14 | 0.16 | -0.11 | 0.02 | 0.87 | 0.1 |
| OPM % | — | — | — | — | 20% | 0% | -23.75% | 12.84% | 23.19% | -19.64% | 3.51% | 31.41% | 9.9% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 |
| PBT | -0.03 | -0.05 | -0.03 | -0.03 | 0.2 | 0 | -0.19 | 0.14 | 0.16 | -0.11 | 0.02 | 0.87 | 0.07 |
| Tax % | 0% | 0% | 0% | 0% | 10% | — | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -0.03 | -0.05 | -0.03 | -0.03 | 0.17 | 0 | -0.19 | 0.14 | 0.16 | -0.11 | 0.02 | 0.87 | 0.07 |
| EPS in Rs | -0.03 | -0.05 | -0.03 | -0.03 | 0.16 | 0 | -0.18 | 0.13 | 0.15 | -0.11 | 0.02 | 0.84 | 0.07 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.4 | 0 | 0 | 0 | 0 | 4.34 | 4.58 | 2.37 | 0 | 1 | 3.07 | 4.9 |
| Expenses | 0.51 | 0.17 | 0.17 | 0.17 | 0.17 | 4.26 | 4.45 | 2.41 | 0.1 | 0.92 | 2.95 | 3.98 |
| Operating Profit | -0.11 | -0.17 | -0.17 | -0.17 | -0.17 | 0.08 | 0.13 | -0.04 | -0.1 | 0.08 | 0.12 | 0.92 |
| OPM % | -27.5% | — | — | — | — | 1.84% | 2.84% | -1.69% | — | 8% | 3.91% | 18.78% |
| Other Income | 0.19 | 0.12 | 0.12 | 0.11 | 0.1 | 0.11 | 0.14 | 0.12 | 0.03 | 0 | 0.01 | 0.13 |
| Interest | 0.09 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 |
| PBT | -0.01 | -0.05 | -0.05 | -0.06 | -0.07 | 0.19 | 0.27 | 0.08 | -0.07 | 0.08 | 0.13 | 0.95 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 15.79% | 22.22% | 25% | 0% | 25% | 23.08% | 26.32% |
| Net Profit | -0.01 | -0.05 | -0.05 | -0.06 | -0.07 | 0.16 | 0.21 | 0.06 | -0.07 | 0.06 | 0.1 | 0.71 |
| EPS in Rs | — | — | — | — | — | — | — | 0.06 | -0.07 | 0.06 | 0.1 | 0.68 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 5.2 |
| Reserves | 1 | 0.95 | 0.69 | 0.63 | 0.56 | 0.72 | 0.93 | 0.99 | 0.92 | 0.98 | 1.08 | 1.79 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.03 |
| Other Liabilities | 0.2 | 0.01 | 0.01 | 0.01 | 0.01 | 0.1 | 0.01 | 0.02 | 0.04 | 0.54 | 0.38 | 0.2 |
| Total Liabilities | 1.4 | 1.16 | 0.9 | 0.84 | 0.77 | 1.02 | 1.14 | 1.21 | 1.16 | 1.72 | 1.67 | 7.22 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.9 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.21 | 0.21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1.19 | 0.95 | 0.9 | 0.84 | 0.77 | 1.02 | 1.14 | 1.21 | 1.16 | 1.72 | 1.67 | 4.32 |
| Total Assets | 1.4 | 1.16 | 0.9 | 0.84 | 0.77 | 1.02 | 1.14 | 1.21 | 1.16 | 1.72 | 1.67 | 7.22 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | -0.01 | 0.01 | 0 | 0 | -0.01 | 0.11 | -0.04 | 0.01 | 0.1 | 1.47 | -0.12 | 0.09 |
| Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3 |
| Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 5 |
| Net Cash Flow | -0.01 | 0.01 | 0 | 0 | -0.01 | 0.11 | -0.04 | 0.01 | 0.11 | 1.47 | -0.12 | 2.09 |
| Free Cash Flow | -0.01 | 0.01 | 0 | 0 | -0.01 | 0.11 | -0.04 | 0.01 | 0.1 | 1.47 | -0.12 | -2.91 |
| CFO/OP | 9 | -6 | 0 | 0 | 6 | 175 | 15 | -75 | -100 | 1,838 | -75 | 37 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | — | — | — | — | 0 | 0 | 0 | — | 0 | 13.08 | 42.46 |
| Inventory Days | 0 | — | — | — | — | 0 | 0 | 0 | — | 0 | 0 | 0 |
| Cash Conversion Cycle | 0 | — | — | — | — | 0 | 0 | 0 | — | 0 | 13.08 | 42.46 |
| Working Capital Days | 894 | — | — | — | — | 66.44 | 82.88 | 166 | — | -164 | -34.48 | 32.78 |
| ROCE % | 6.67% | -4.26% | -4.9% | -6.98% | -8.81% | 22.62% | 26.34% | 6.9% | -6.06% | 6.96% | 10.53% | 22.86% |
Documents
1
Submission Of Reply To Warning Letter Regarding Delay In Filing Application For Change Of Name.
8 May - Company replied to BSE warning letter on 08-May-2026 over delayed name-change filing after right issue. 8 May - Company replied to BSE warning letter on 08-May-2026 over delayed name-change filing after right issue.
2
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
29 Apr - Apollo Ingredients confirms it is not a SEBI Large Corporate; outstanding borrowing was nil on 31 March 2026. 29 Apr - Apollo Ingredients confirms it is not a SEBI Large Corporate; outstanding borrowing was nil on 31 March 2026.
3
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
29 Apr - Apollo Ingredients confirms it is not a SEBI Large Corporate; outstanding borrowing was nil on 31 March 2026. 29 Apr - Apollo Ingredients confirms it is not a SEBI Large Corporate; outstanding borrowing was nil on 31 March 2026.
4
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
13 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026. 13 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026.
5
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association 29 Jun 2026
General_Announcements
Frequently Asked Questions about Apollo Ingredients Ltd
What does Apollo Ingredients Ltd do?
Incorporated in 1980, Apollo Ingredients Ltd is
in the business of providing healthcare solutions[1]
Where is Apollo Ingredients Ltd (503639) listed?
Apollo Ingredients Ltd is listed on the Indian stock exchanges. It is listed on NSE: INDSOYALTD and BSE: APOLLOIN. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Apollo Ingredients Ltd belong to?
Apollo Ingredients Ltd operates in the Commercial Services sector within the Diversified Services industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Apollo Ingredients Ltd?
Apollo Ingredients Ltd has a market capitalisation of approximately ₹115.20 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Apollo Ingredients Ltd?
The Price-to-Earnings (PE) ratio of Apollo Ingredients Ltd is 162.90. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Apollo Ingredients Ltd?
Over the past 52 weeks, Apollo Ingredients Ltd has traded between a low of ₹5.43 and a high of ₹110.78. This range helps investors understand the stock's price volatility and recent trading levels.
What is the Return on Equity (ROE) of Apollo Ingredients Ltd?
Apollo Ingredients Ltd has a Return on Equity (ROE) of 10.14%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Apollo Ingredients Ltd on Tapetide?
On Tapetide, you can view Apollo Ingredients Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Incorporated in 1980, Apollo Ingredients Ltd is in the business of providing healthcare solutions[1]